Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-01554-0002-0000-9 |
Chemical Name: | 6-Methoxy-2-benzothiazolamine |
CASRN: | 1747-60-0 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 773945_CA |
Study Result: | Positive |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Weakly Positive |
Induced Rat Liver S9 | 1_S9 | Positive |
Induced Rat Liver S9 | 2_S9 | Positive |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Dimethyl Sulfoxide | 0 | 200 | 1 | 0.005 | 0.5 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 |
Test Chemical: | 6-Methoxy-2-benzothiazolamine | 160 | 200 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 |
300 | 200 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
500 | 200 | 31 | 0.155 | 5.0 | 1 | 0.005 | 0.5 | 20 | 0.100 | 4.5 | 10 | 0.050 | 1.0 | ||
Positive Control: | Mitomycin-C | 0.0625 | 200 | 35 | 0.175 | 15.5 | 14 | 0.070 | 6.5 | 21 | 0.105 | 10.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.25 | 50 | 20 | 0.400 | 32.0 | 15 | 0.300 | 26.0 | 5 | 0.100 | 8.0 | 0 | 0.000 | 0.0 | |
Trend: | 3.265 | -0.032 | 3.587 | ||||||||||||
Probability: | 0.001 | 0.513 | 0.000 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Dimethyl Sulfoxide | 0 | 200 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 |
Test Chemical: | 6-Methoxy-2-benzothiazolamine | 100 | 200 | 51 | 0.255 | 12.5 | 9 | 0.045 | 4.0 | 32 | 0.160 | 10.0 | 10 | 0.050 | 1.0 |
160 | 200 | 108 | 0.540 | 26.0 | 53 | 0.265 | 17.0 | 54 | 0.270 | 17.5 | 1 | 0.005 | 1.0 | ||
300 | 200 | 175 | 0.875 | 36.0 | 97 | 0.485 | 28.5 | 77 | 0.385 | 25.5 | 1 | 0.005 | 1.0 | ||
500 | 70 | 92 | 1.314 | 65.7 | 21 | 0.300 | 21.4 | 51 | 0.729 | 58.6 | 20 | 0.286 | 2.0 | ||
Positive Control: | Cyclophosphamide | 2.5 | 200 | 43 | 0.215 | 18.0 | 12 | 0.060 | 6.0 | 31 | 0.155 | 14.5 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 7.5 | 50 | 30 | 0.600 | 44.0 | 8 | 0.160 | 14.0 | 22 | 0.440 | 34.0 | 0 | 0.000 | 0.0 | |
Trend: | 12.468 | 8.943 | 11.032 | ||||||||||||
Probability: | 0.000 | 0.000 | 0.000 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Dimethyl Sulfoxide | 0 | 200 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
Test Chemical: | 6-Methoxy-2-benzothiazolamine | 160 | 200 | 81 | 0.405 | 25.0 | 27 | 0.135 | 10.0 | 54 | 0.270 | 18.5 | 0 | 0.000 | 0.0 |
300 | 200 | 49 | 0.245 | 16.5 | 19 | 0.095 | 8.0 | 30 | 0.150 | 12.0 | 0 | 0.000 | 0.0 | ||
500 | 200 | 65 | 0.325 | 28.5 | 14 | 0.070 | 6.5 | 51 | 0.255 | 24.5 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 2.5 | 200 | 36 | 0.180 | 17.0 | 4 | 0.020 | 2.0 | 32 | 0.160 | 15.5 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 7.5 | 50 | 20 | 0.400 | 28.0 | 2 | 0.040 | 4.0 | 18 | 0.360 | 26.0 | 0 | 0.000 | 0.0 | |
Trend: | 6.036 | 2.333 | 5.731 | ||||||||||||
Probability: | 0.000 | 0.010 | 0.000 |